- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 313/06 - Sulfinamides
Patent holdings for IPC class C07C 313/06
Total number of patents in this class: 58
10-year publication summary
|
2
|
4
|
6
|
4
|
5
|
6
|
6
|
6
|
8
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Peloton Therapeutics, Inc. | 37 |
4 |
| Novartis AG | 10882 |
3 |
| Vitae Pharmaceuticals, Inc. | 96 |
3 |
| Oxford Drug Design Limited | 9 |
3 |
| Nikang Therapeutics, Inc. | 95 |
3 |
| Orsobio, Inc. | 13 |
3 |
| Boehringer Ingelheim International GmbH | 4705 |
2 |
| Alkermes Pharma Ireland Limited | 270 |
2 |
| Cytokinetics, Inc. | 273 |
2 |
| Piramal Pharma Limited | 53 |
2 |
| Genentech, Inc. | 3976 |
1 |
| Bayer Intellectual Property GmbH | 2519 |
1 |
| FUJIFILM Corporation | 29273 |
1 |
| Ricoh Company, Ltd. | 13205 |
1 |
| ABX Advanced Biochemical Compounds GmbH | 12 |
1 |
| Amira Pharmaceuticals, Inc. | 70 |
1 |
| Arbutus Biopharma Corporation | 177 |
1 |
| Kinex Pharmaceuticals, LLC | 11 |
1 |
| Nanjing University | 724 |
1 |
| Nanyang Technological University | 1989 |
1 |
| Other owners | 21 |